Illuminating the State of Outsourcing with Stephen Houldsworth (DCAT 2023)
Stephen Houldsworth, VP and Head of Platform Management & Marketing at CordenPharma, dives into ongoing trends in the outsourcing space.
As part of ongoing coverage of DCAT, the PharmTech editors touched base with Stephen Houldsworth, vice-president and head of Platform Management & Marketing at CordenPharma. In in our discussion, Stephen touched on various topics within the outsourcing market, including:
- Recent investments and the strategic rationale behind them.
- Ongoing industry trends and what customers are looking for.
- Bold predictions for where the industry will be five years down the line.
For more of our coverage on DCAT in 2023, viewers can visit this page.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
